With Twitter (Now X) in Flux, Is #MedTwitter Under Threat?
Oncology professionals share what #MedTwitter means to them and where they might go if Twitter (now X) becomes obsolete.
Oncology professionals share what #MedTwitter means to them and where they might go if Twitter (now X) becomes obsolete.
Most patients had at least 1 biomarker test, but only 46% had all 5 biomarker tests.
Researchers found that CROSS is not inferior to MAGIC/FLOT, supporting it’s place in decision making for patients with locally advanced esophageal cancer.
Researchers have identified a potentially new first-line treatment option for patients with advanced or metastatic esophageal squamous cell carcinoma.
Nivolumab plus chemotherapy improved overall survival.
Adjuvant nivolumab prolonged distant metastasis-free survival.